DPP4 and metabolic dysfunction-associated steatotic liver disease: In order to confirm the finding of an association between increased plasma DPP4 activity and NAFLD diagnosis in non-severe obese subjects, we analysed data from an additional cohort of 126 individual with and without MS and/or T2DM undergoing liver US examination to screen NAFLD.